Pular para conteúdo

Cirurgia vascular e cardiotorácica (pediatria)

Manejo e otimização da hemostasia

Antifibrinolíticos 

Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (abre nova janela)

Arnold DM, Fergusson DA, Chan AK, Cook RJ, Fraser GA, Lim W, Blajchman MA, Cook DJ.

Fonte‎: Anesth Analg 2006;102(3):731-7.

Indexado‎: PubMed 16492820

DOI‎: 10.1213/01.ane.0000194954.64293.61

https://www.ncbi.nlm.nih.gov/pubmed/16492820 (abre nova janela)

A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (abre nova janela)

Basta MN, Stricker PA, Taylor JA.

Fonte‎: Pediatr Surg Int 2012;28(11):1059-69.

Indexado‎: PubMed 22940882

DOI‎: 10.1007/s00383-012-3167-6

https://www.ncbi.nlm.nih.gov/pubmed/22940882 (abre nova janela)

Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (abre nova janela)

Bojan M, Vicca S, Boulat C, Gioanni S, Pouard P.

Fonte‎: Br J Anaesth 2012;108(5):830-7.

Indexado‎: PubMed 22362670

DOI‎: 10.1093/bja/aes002

https://www.ncbi.nlm.nih.gov/pubmed/22362670 (abre nova janela)

Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (abre nova janela)

Chauhan S, Das SN, Bisoi A, Kale S, Kiran U.

Fonte‎: J Cardiothorac Vasc Anesth 2004;18(2):141-3.

Indexado‎: PubMed 15073700

https://www.ncbi.nlm.nih.gov/pubmed/15073700 (abre nova janela)

Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (abre nova janela)

Chauhan S, Kumar BA, Rao BH, Rao MS, Dubey B, Saxena N, Venugopal P.

Fonte‎: Ann Thorac Surg 2000;70(4):1308-12.

Indexado‎: PubMed 11081890

https://www.ncbi.nlm.nih.gov/pubmed/11081890 (abre nova janela)

Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (abre nova janela)

Graham EM, Atz AM, Gillis J, Desantis SM, Haney AL, Deardorff RL, Uber WE, Reeves ST, McGowan FX Jr, Bradley SM, Spinale FG.

Fonte‎: J Thorac Cardiovasc Surg 2012;143(5):1069-76.

Indexado‎: PubMed 22075061

DOI‎: 10.1016/j.jtcvs.2011.08.051

https://www.ncbi.nlm.nih.gov/pubmed/22075061 (abre nova janela)

Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (abre nova janela)

Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Tanaka A, Noda R, Yokoyama S, Iwasaki K.

Fonte‎: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.

Indexado‎: PubMed 24637029

DOI‎: 10.1177/0218492314527991

https://www.ncbi.nlm.nih.gov/pubmed/24637029 (abre nova janela)

The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (abre nova janela)

Lin CY, Shuhaiber JH, Loyola H, Liu H, Del Nido P, DiNardo JA, Pigula FA.

Fonte‎: PLoS One 2015;10(5):e0126514.

Indexado‎: PubMed 25954976

DOI‎: 10.1371/journal.pone.0126514

https://www.ncbi.nlm.nih.gov/pubmed/25954976 (abre nova janela)

Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (abre nova janela)

Martin K, Breuer T, Gertler R, Hapfelmeier A, Schreiber C, Lange R, Hess J, Wiesner G.

Fonte‎: Eur J Cardiothorac Surg 2011;39(6):892-7.

Indexado‎: PubMed 21115357

DOI‎: 10.1016/j.ejcts.2010.09.041

https://www.ncbi.nlm.nih.gov/pubmed/21115357 (abre nova janela)

Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (abre nova janela)

Martin K, Gertler R, MacGuill M, Mayr NP, Hapfelmeier A, Hörer J, Vogt M, Tassani P, Wiesner G.

Fonte‎: Br J Anaesth 2013;110(4):615-21.

Indexado‎: PubMed 23213034

DOI‎: 10.1093/bja/aes430

https://www.ncbi.nlm.nih.gov/pubmed/23213034 (abre nova janela)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (abre nova janela)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Fonte‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Indexado‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (abre nova janela)

Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (abre nova janela)

Muthialu N, Balakrishnan S, Sundar R, Muralidharan S.

Fonte‎: Ann Card Anaesth 2015;18(1):23-6.

Indexado‎: PubMed 25566706

DOI‎: 10.4103/0971-9784.148316

https://www.ncbi.nlm.nih.gov/pubmed/25566706 (abre nova janela)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (abre nova janela)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Fonte‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indexado‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (abre nova janela)

Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (abre nova janela)

Rozen L, Faraoni D, Sanchez Torres C, Willems A, Noubouossie DC, Barglazan D, Van der Linden P, Demulder A.

Fonte‎: Eur J Anaesthesiol 2015;32(12):844-50.

Indexado‎: PubMed 26258658

DOI‎: 10.1097/EJA.0000000000000316

https://www.ncbi.nlm.nih.gov/pubmed/26258658 (abre nova janela)

Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (abre nova janela)

Sarupria A, Makhija N, Lakshmy R, Kiran U.

Fonte‎: J Cardiothorac Vasc Anesth 2013;27(1):23-9.

Indexado‎: PubMed 22995453

DOI‎: 10.1053/j.jvca.2012.07.001

https://www.ncbi.nlm.nih.gov/pubmed/22995453 (abre nova janela)

Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (abre nova janela)

Verma YS, Chauhan S, Bisoi AK, Gharde P, Kiran U, Das SN.

Fonte‎: Ann Card Anaesth 2010;13(2):110-5.

Indexado‎: PubMed 20442540

DOI‎: 10.4103/0971-9784.62935

https://www.ncbi.nlm.nih.gov/pubmed/20442540 (abre nova janela)

Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (abre nova janela)

Wesley MC, Pereira LM, Scharp LA, Emani SM, McGowan FX Jr, DiNardo JA.

Fonte‎: Anesthesiology 2015;122(4):746-58.

Indexado‎: PubMed 25585004

DOI‎: 10.1097/ALN.0000000000000570

https://www.ncbi.nlm.nih.gov/pubmed/25585004 (abre nova janela)

Efficacy and safety of aprotinin in neonatal congenital heart operations. (abre nova janela)

Wilder NS, Kavarana MN, Voepel-Lewis T, Paugh T, Lee T, Ohye RG.

Fonte‎: Ann Thorac Surg 2011;92(3):958-63.

Indexado‎: PubMed 21871283

DOI‎: 10.1016/j.athoracsur.2011.04.094

https://www.ncbi.nlm.nih.gov/pubmed/21871283 (abre nova janela)

The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (abre nova janela)

Zonis Z, Seear M, Reichert C, Sett S, Allen C.

Fonte‎: J Thorac Cardiovasc Surg 1996;111(5):982-7.

Indexado‎: PubMed 8622323

https://www.ncbi.nlm.nih.gov/pubmed/8622323 (abre nova janela)

Fator VII recombinante ativado (rFVIIa)

Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (abre nova janela)

Agarwal HS, Bennett JE, Churchwell KB, Christian KG, Drinkwater DC Jr, He Y, Taylor MB.

Fonte‎: Ann Thorac Surg 2007;84(1):161-8.

Indexado‎: PubMed 17588404

DOI‎: 10.1016/j.athoracsur.2007.02.051

https://www.ncbi.nlm.nih.gov/pubmed/17588404 (abre nova janela)

Pediatric off-label use of recombinant factor VIIa. (abre nova janela)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Fonte‎: Pediatrics 2009;123(3):1066-72.

Indexado‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (abre nova janela)

Factor VII for excessive bleeding following congenital heart disease surgery. (abre nova janela)

Changlani DK, Devendaran V, Murmu UC, Ganesan S, Varghese R, Kumar RS.

Fonte‎: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.

Indexado‎: PubMed 22499956

DOI‎: 10.1177/0218492311433614

https://www.ncbi.nlm.nih.gov/pubmed/22499956 (abre nova janela)

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (abre nova janela)

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Fonte‎: Paediatr Anaesth 2009;19(4):364-70.

Indexado‎: PubMed 19143947

DOI‎: 10.1111/j.1460-9592.2008.02905.x

https://www.ncbi.nlm.nih.gov/pubmed/19143947 (abre nova janela)

Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (abre nova janela)

Guzzetta NA, Russell IA, Williams GD.

Fonte‎: Anesth Analg 2012;115(2):364-78.

Indexado‎: PubMed 22652310

DOI‎: 10.1213/ANE.0b013e31825aff10

https://www.ncbi.nlm.nih.gov/pubmed/22652310 (abre nova janela)

Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (abre nova janela)

Okonta KE, Edwin F, Falase B.

Fonte‎: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.

Indexado‎: PubMed 22811512

DOI‎: 10.1093/icvts/ivs309

https://www.ncbi.nlm.nih.gov/pubmed/22811512 (abre nova janela)

Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (abre nova janela)

Pérez-Ferrer A, Gredilla E, de Vicente J, Laporta Y.

Fonte‎: J Cardiothorac Vasc Anesth 2012;26(4):651-3.

Indexado‎: PubMed 21924639

DOI‎: 10.1053/j.jvca.2011.07.012

https://www.ncbi.nlm.nih.gov/pubmed/21924639 (abre nova janela)

Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (abre nova janela)

Pychyńska-Pokorska M, Pągowska-Klimek I, Krajewski W, Moll JJ.

Fonte‎: J Cardiothorac Vasc Anesth 2011;25(6):987-94.

Indexado‎: PubMed 21835642

DOI‎: 10.1053/j.jvca.2011.05.012

https://www.ncbi.nlm.nih.gov/pubmed/21835642 (abre nova janela)

Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (abre nova janela)

Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.

Fonte‎: J Clin Anesth 2014;26(3):204-11.

Indexado‎: PubMed 24809789

DOI‎: 10.1016/j.jclinane.2013.10.015

https://www.ncbi.nlm.nih.gov/pubmed/24809789 (abre nova janela)

Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (abre nova janela)

Singh SP, Chauhan S, Choudhary M, Vasdev S, Talwar S.

Fonte‎: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.

Indexado‎: PubMed 22371937

DOI‎: 10.1177/0218492311432584

https://www.ncbi.nlm.nih.gov/pubmed/22371937 (abre nova janela)

Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (abre nova janela)

Tobias JD, Berkenbosch JW, Russo P.

Fonte‎: Pediatr Crit Care Med 2003;4(1):49-51.

Indexado‎: PubMed 12656542

DOI‎: 10.1097/01.PCC.0000031472.55687.4E

https://www.ncbi.nlm.nih.gov/pubmed/12656542 (abre nova janela)

Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (abre nova janela)

Tobias JD, Simsic JM, Weinstein S, Schechter W, Kartha V, Michler R.

Fonte‎: J Intensive Care Med 2004;19(5):270-3.

Indexado‎: PubMed 15358945

DOI‎: 10.1177/0885066604267783

https://www.ncbi.nlm.nih.gov/pubmed/15358945 (abre nova janela)

Recombinant activated factor VII in cardiac surgery: a systematic review. (abre nova janela)

Warren O, Mandal K, Hadjianastassiou V, Knowlton L, Panesar S, John K, Darzi A, Athanasiou T.

Fonte‎: Ann Thorac Surg 2007;83(2):707-14.

Indexado‎: PubMed 17258029

DOI‎: 10.1016/j.athoracsur.2006.10.033

https://www.ncbi.nlm.nih.gov/pubmed/17258029 (abre nova janela)

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (abre nova janela)

Warren OJ, Rogers PL, Watret AL, de Wit KL, Darzi AW, Gill R, Athanasiou T.

Fonte‎: Pediatr Crit Care Med 2009;10(5):572-82.

Indexado‎: PubMed 19451849

DOI‎: 10.1097/PCC.0b013e3181a642d5

https://www.ncbi.nlm.nih.gov/pubmed/19451849 (abre nova janela)

Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (abre nova janela)

Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD.

Fonte‎: Pediatr Cardiol 2013;34(1):119-24.

Indexado‎: PubMed 22760694

DOI‎: 10.1007/s00246-012-0398-1

https://www.ncbi.nlm.nih.gov/pubmed/22760694 (abre nova janela)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (abre nova janela)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Fonte‎: Pediatr Hematol Oncol 2008;25(4):301-11.

Indexado‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (abre nova janela)

Concentrados de fatores de coagulação 

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (abre nova janela)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Fonte‎: Artif Organs 2010;34(11):955-60.

Indexado‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (abre nova janela)

Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (abre nova janela)

Faraoni D, Willems A, Savan V, Demanet H, De Ville A, Van der Linden P.

Fonte‎: Eur J Anaesthesiol 2014;31(6):317-26.

Indexado‎: PubMed 24503704

DOI‎: 10.1097/EJA.0000000000000043

https://www.ncbi.nlm.nih.gov/pubmed/24503704 (abre nova janela)

Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (abre nova janela)

Fominskiy E, Nepomniashchikh VA, Lomivorotov VV, Monaco F, Vitiello C, Zangrillo A, Landoni G.

Fonte‎: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.

Indexado‎: PubMed 27493092

DOI‎: 10.1053/j.jvca.2016.04.015

https://www.ncbi.nlm.nih.gov/pubmed/27493092 (abre nova janela)

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (abre nova janela)

Galas FR, de Almeida JP, Fukushima JT, Vincent JL, Osawa EA, Zeferino S, Câmara L, Guimarães VA, Jatene MB, Hajjar LA.

Fonte‎: J Thorac Cardiovasc Surg 2014;148(4):1647-55.

Indexado‎: PubMed 24951020

DOI‎: 10.1016/j.jtcvs.2014.04.029

https://www.ncbi.nlm.nih.gov/pubmed/24951020 (abre nova janela)

Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (abre nova janela)

Noga T, Bruce AA, Blain H, Nahirniak S.

Fonte‎: Vox Sang 2016;110(3):253-7.

Indexado‎: PubMed 26509839

DOI‎: 10.1111/vox.12353

https://www.ncbi.nlm.nih.gov/pubmed/26509839 (abre nova janela)

Agentes hemostáticos de uso tópico

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (abre nova janela)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

Fonte‎: Ann Surg 2010;251(2):217-28.

Indexado‎: PubMed 20010084

DOI‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (abre nova janela)

Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (abre nova janela)

Pace Napoleone C, Oppido G, Angeli E, Gargiulo G.

Fonte‎: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.

Indexado‎: PubMed 17669759

DOI‎: 10.1510/icvts.2006.141531

https://www.ncbi.nlm.nih.gov/pubmed/17669759 (abre nova janela)

Testes viscoelásticos para identificar sangramento cirúrgico ou coagulopático

Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (abre nova janela)

Aggarwal V, Kapoor PM, Choudhury M, Kiran U, Chowdhury U.

Fonte‎: Ann Card Anaesth 2012;15(1):26-31.

Indexado‎: PubMed 22234018

DOI‎: 10.4103/0971-9784.91477

https://www.ncbi.nlm.nih.gov/pubmed/22234018 (abre nova janela)

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (abre nova janela)

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Fonte‎: Artif Organs 2010;34(11):955-60.

Indexado‎: PubMed 21092037

DOI‎: 10.1111/j.1525-1594.2010.01148.x

https://www.ncbi.nlm.nih.gov/pubmed/21092037 (abre nova janela)

Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (abre nova janela)

Nakayama Y, Nakajima Y, Tanaka KA, Sessler DI, Maeda S, Iida J, Ogawa S, Mizobe T.

Fonte‎: Br J Anaesth 2015;114(1):91-102.

Indexado‎: PubMed 25303988

DOI‎: 10.1093/bja/aeu339

https://www.ncbi.nlm.nih.gov/pubmed/25303988 (abre nova janela)

CIRURGIA VASCULAR E CARDIOTORÁCICA (PEDIATRIA)
Manejo e otimização da hemostasia
Português (Brasil)
Manejo e otimização da hemostasia
https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Contate um representante da Comissão de Ligação com Hospitais

Um serviço mundial gratuito disponível 24 horas por dia para médicos que tratam Testemunhas de Jeová.

Contato

Conteúdos para baixar

Assuntos incluem: métodos clínicos para controlar hemorragia e anemia sem o uso de transfusões de sangue, a posição ética e religiosa das Testemunhas de Jeová sobre tratamentos médicos e uma descrição da contribuição que as Testemunhas de Jeová fazem na área médica por meio das Comissões de Ligação com Hospitais.

Visualizar downloads

Vídeos

Opções de tratamento e considerações médicas e éticas para médicos que tratam Testemunhas de Jeová.

Vídeos